Oligomer Formation of Tau Protein Hyperphosphorylated in Cells*

Background: The causal relationship between Tau hyperphosphorylation and aggregation in neuropathology is still under debate. Results: Tau highly phosphorylated in cells increases oligomerization without pronounced aggregation. Oligomers cause reduction of dendritic spines but not cell death. Conclusion: Hyperphosphorylation does not drive Tau fibrillization but contributes to synaptotoxicity. Significance: Pathways and effects of Tau hyperphosphorylation are distinct from those of aggregation. Abnormal phosphorylation (“hyperphosphorylation”) and aggregation of Tau protein are hallmarks of Alzheimer disease and other tauopathies, but their causative connection is still a matter of debate. Tau with Alzheimer-like phosphorylation is also present in hibernating animals, mitosis, or during embryonic development, without leading to pathophysiology or neurodegeneration. Thus, the role of phosphorylation and the distinction between physiological and pathological phosphorylation needs to be further refined. So far, the systematic investigation of highly phosphorylated Tau was difficult because a reliable method of preparing reproducible quantities was not available. Here, we generated full-length Tau (2N4R) in Sf9 cells in a well defined phosphorylation state containing up to ∼20 phosphates as judged by mass spectrometry and Western blotting with phospho-specific antibodies. Despite the high concentration in living Sf9 cells (estimated ∼230 μm) and high phosphorylation, the protein was not aggregated. However, after purification, the highly phosphorylated protein readily formed oligomers, whereas fibrils were observed only rarely. Exposure of mature primary neuronal cultures to oligomeric phospho-Tau caused reduction of spine density on dendrites but did not change the overall cell viability.

• Publication year

  2014

• Venue

  Journal of Biological Chemistry

• Publication date

  2014-10-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.M114.611368PMID 25339173PMCID 4256367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer’s Disease Genetics

  2014cited by this paper
• Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity*

  2014cited by this paper
• Amyloid‐β oligomers induce synaptic damage via Tau‐dependent microtubule severing by TTLL6 and spastin

  2013cited by this paper
• Conserved features of intermediates in amyloid assembly determine their benign or toxic states

  2012cited by this paper
• The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

  2012cited by this paper
• FLEXIQinase, a mass spectrometry-based assay, to unveil multi-kinase mechanisms

  2012cited by this paper
• Soluble forms of tau are toxic in Alzheimer’s disease

  2012cited by this paper
• Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein

  2012cited by this paper
• Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.

  2012cited by this paper
• The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system.

  2012cited by this paper
• Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant

  2011cited by this paper
• The Physiological Link between Metabolic Rate Depression and Tau Phosphorylation in Mammalian Hibernation

  2011cited by this paper
• Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease

  2011cited by this paper
• Altered phosphorylation but no neurodegeneration in a mouse model of tau hyperphosphorylation.

  2011cited by this paper
• The acetylation of tau inhibits its function and promotes pathological tau aggregation.

  2011cited by this paper
• In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice

  2011cited by this paper
• The role of tau kinases in Alzheimer's disease.

  2010cited by this paper
• Acetylation of tau inhibits its degradation and contributes to tauopathy.

  2010cited by this paper
• NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease.

  2010cited by this paper
• Tau aggregation is a therapeutic target for Alzheimer's disease.

  2010cited by this paper
• Preparation and characterization of neurotoxic tau oligomers.

  2010cited by this paper
• Structural Polymorphism of 441-Residue Tau at Single Residue Resolution

  2009cited by this paper
• Quantitative Characterization of Heparin Binding to Tau Protein

  2009cited by this paper
• Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases

  2009cited by this paper
• Practical protocols for production of very high yields of recombinant proteins using Escherichia coli

  2009cited by this paper
• Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.

  2009influential reference
• Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases*

  2008cited by this paper
• Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration.

  2008cited by this paper
• Beta-lactoglobulin assembles into amyloid through sequential aggregated intermediates.

  2008cited by this paper
• The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.

  2008cited by this paper
• Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

  2007cited by this paper
• Swimming against the Tide: Mobility of the Microtubule-Associated Protein Tau in Neurons

  2007cited by this paper
• Granular tau oligomers as intermediates of tau filaments.

  2007cited by this paper
• Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model

  2007cited by this paper
• Tau Aggregation in Alzheimer's Disease

  2007cited by this paper
• HSP induction mediates selective clearance of tau phosphorylated at proline‐directed Ser/Thr sites but not KXGS (MARK) sites

  2006cited by this paper
• Infectious disease: Unravelling SARS lethality

  2005cited by this paper
• Tau phosphorylation in Alzheimer's disease: pathogen or protector?

  2005cited by this paper
• Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

  2005cited by this paper
• Efficient uniform isotope labeling of Abl kinase expressed in Baculovirus-infected insect cells

  2005cited by this paper
• Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease

  2005cited by this paper
• Tau phosphorylation: physiological and pathological consequences.

  2005cited by this paper
• Pseudophosphorylation of tau protein alters its ability for self‐aggregation

  2004cited by this paper
• Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain.

  2004cited by this paper
• The effect of macromolecular crowding on protein aggregation and amyloid fibril formation

  2004cited by this paper
• Glycogen Synthase Kinase 3β Phosphorylates Tau at Both Primed and Unprimed Sites

  2003cited by this paper
• Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease

  2003cited by this paper
• Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding.

  2003cited by this paper
• Reversible Paired Helical Filament-Like Phosphorylation of Tau Is an Adaptive Process Associated with Neuronal Plasticity in Hibernating Animals

  2003cited by this paper
• Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments.

  2002cited by this paper
• Microtubule-associated protein 1B

  2002cited by this paper
• Topics in fluorescence spectroscopy

  2002cited by this paper
• Pioneering Contributions of Jean and Francis Perrin to Molecular Luminescence

  2001cited by this paper
• Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments

  2001influential reference
• Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein.

  2001cited by this paper
• Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure.

  2000cited by this paper
• Defects in Axonal Elongation and Neuronal Migration in Mice with Disrupted tau and map1b Genes

  2000cited by this paper
• The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains.

  1999cited by this paper
• Alexa Dyes, a Series of New Fluorescent Dyes that Yield Exceptionally Bright, Photostable Conjugates

  1999cited by this paper
• Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.

  1999cited by this paper
• Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease.

  1998influential reference
• Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution.

  1998cited by this paper
• 1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation.

  1998cited by this paper
• MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption.

  1997cited by this paper
• Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.

  1997cited by this paper
• Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules

  1996cited by this paper
• Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

  1996cited by this paper
• Mitotic mechanisms in Alzheimer's disease?

  1996influential reference
• Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments.

  1995cited by this paper
• Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau.

  1994cited by this paper
• Domains of tau protein and interactions with microtubules.

  1994cited by this paper
• Microtubule-associated protein function: lessons from expression in Spodoptera frugiperda cells.

  1994cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments.

  1993cited by this paper
• Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding.

  1993cited by this paper
• Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease.

  1993cited by this paper
• Phosphorylated baculovirus p10 is a heat-stable microtubule-associated protein associated with process formation in Sf9 cells.

  1992cited by this paper
• Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.

  1992cited by this paper
• Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain.

  1992cited by this paper
• Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments.

  1992cited by this paper
• A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

  1991cited by this paper
• Near‐infrared spark source excitation for fluorescence lifetime measurements

  1991cited by this paper
• Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections

  1991cited by this paper
• Processes induced by tau expression in Sf9 cells have an axon-like microtubule organization

  1991cited by this paper
• Cell volume increase in Escherichia coli after shifts to richer media

  1990cited by this paper
• A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.

  1990cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper
• Studies on the expression of the microtubule-associated protein, tau, during mouse brain development, with newly isolated complementary DNA probes

  1984influential reference
• Involvement of the carboxyl-terminal domain of tubulin in the regulation of its assembly.

  1984cited by this paper
• Radioimmunoassay for tubulin: a quantitative comparison of the tubulin content of different established tissue culture cells and tissues.

  1978cited by this paper
• Glycogen Synthase Kinase 3 (cid:1) Phosphorylates Tau at Both Primed and Unprimed Sites

  year unknowncited by this paper

• Brain-derived tau oligomer polymorphs: distinct aggregations, stability profiles, and biological activities

  2025cites this paper
• Artificial cells with liquid-liquid phase separation-regulated cell-free protein synthesis.

  2025cites this paper
• Rare bioactive tau oligomers from Alzheimer brain support both templated misfolding and fibril formation

  2025cites this paper
• Apolipoprotein E and Tau interaction in Alzheimer's disease.

  2025cites this paper
• A brain‐derived tau oligomer polymorph is associated with cognitive resilience to Alzheimer's disease

  2025cites this paper
• Specific phosphorylation patterns control the interplay between aggregation and condensation of Tau-R4 peptides.

  2025cites this paper
• PP2A methylesterase, PME‐1, and PP2A methyltransferase, LCMT‐1, control sensitivity to impairments caused by injury‐related oligomeric tau

  2025cites this paper
• Hyperphosphorylated tau-based Alzheimer’s Disease drug discovery: Identification of inhibitors of tau aggregation and cytotoxicity

  2025cites this paper
• A pathological phosphorylation pattern enhances tau cooperativity on microtubules and facilitates tau filament assembly

  2025cites this paper
• Alzheimer's disease patient-derived high-molecular-weight tau impairs bursting in hippocampal neurons.

  2025cites this paper
• Internalization of extracellular Tau oligomers in Alzheimer's disease.

  2025cites this paper
• Making tau amyloid models in vitro: a crucial and underestimated challenge

  2025cites this paper
• A pathological phosphorylation pattern enhances tau cooperativity on microtubules and facilitates tau filament assembly

  2025cites this paper
• Tau in Multiple Sclerosis: A Review of Therapeutic Potential

  2025cites this paper
• Phosphorylation regulates tau’s phase separation behavior and interactions with chromatin

  2024cites this paper
• Marmosets as model systems for the study of Alzheimer's disease and related dementias: Substantiation of physiological tau 3R and 4R isoform expression and phosphorylation

  2024cites this paper
• Pilot Study for Deciphering Post-Translational Modifications and Proteoforms of Tau Protein by Capillary Electrophoresis-Mass Spectrometry

  2024cites this paper
• The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges

  2024cites this paper
• SORL1 is a receptor for tau that promotes tau seeding

  2024cites this paper
• Phosphorylation of Tau Protein by CDK2/cyclin A and GSK3β Recombinant Kinases: Analysis of Phosphorylation Patterns by Nuclear Magnetic Resonance Spectroscopy.

  2024cites this paper
• Purinergic Receptor P2Y12-Mediated Tau Internalization in Microglia.

  2024cites this paper
• Heterologous expression and fibrillary characterization of the microtubule-binding domain of tau associated with tauopathies

  2024cites this paper
• An autopsy case of progressive supranuclear palsy treated with monoclonal antibody against tau

  2023cites this paper
• Phosphorylation regulates tau’s phase separation behavior and interactions with chromatin

  2023cites this paper
• Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

  2023cites this paper
• Tau oligomerization on microtubules in health and disease

  2023cites this paper
• Phosphorylation of a Cleaved Tau Proteoform at a Single Residue Inhibits Binding to the E3 Ubiquitin Ligase, CHIP

  2023cites this paper
• Increased G3BP2-Tau interaction in tauopathies is a natural defense against Tau aggregation.

  2023influential citation
• The E3 Ubiquitin Ligase, CHIP/STUB1, Inhibits Aggregation of Phosphorylated Proteoforms of Microtubule-associated Protein Tau (MAPT).

  2023cites this paper
• An easy and straightforward synthesized nano calcium phosphate for highly capture of multiply phosphorylated peptides.

  2023cites this paper
• Phase-Separated Subcellular Compartmentation and Related Human Diseases

  2022cites this paper
• Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools

  2022cites this paper
• Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses

  2022cites this paper
• [64Cu]Cu-Albumin Clearance Imaging to Evaluate Lymphatic Efflux of Cerebrospinal Space Fluid in Mouse Model

  2022cites this paper
• Heterogeneous Tau Oligomers as Molecular Targets for Alzheimer’s Disease and Related Tauopathies

  2022cites this paper
• Identification of Novel Kinases of Tau Using Fluorescence Complementation Mass Spectrometry (FCMS)

  2022cites this paper
• Site-Specific C-Terminal Fluorescent Labeling of Tau Protein

  2022cites this paper
• Macromolecular structures and proteins interacting with the microtubule associated tau protein.

  2022cites this paper
• Recent advances in cellular biosensor technology to investigate tau oligomerization

  2021cites this paper
• Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein.

  2021cites this paper
• Improved Performance and Phosphoproteome Coverage by Magnetic Microparticles for Phosphopeptide Affinity Enrichment

  2021cites this paper
• The effect of the use of copper carbonate and copper nanoparticles in the diet of rats on the level of β-amyloid and acetylcholinesterase in selected organs.

  2021cites this paper
• Conformational fingerprinting of tau variants and strains by Raman spectroscopy

  2021cites this paper
• A current view on Tau protein phosphorylation in Alzheimer's disease.

  2021cites this paper
• Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism

  2021cites this paper
• Microglial remodeling of actin network by Tau oligomers, via G protein‐coupled purinergic receptor, P2Y12R‐driven chemotaxis

  2021cites this paper
• Tau Oligomers Neurotoxicity

  2021cites this paper
• Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease

  2021cites this paper
• THE ROLE OF MICROTUBULE-ASSOCIATED PROTEIN TAU IN NEURONAL EXCITABILITY AND EPILEPTOGENESIS

  2021cites this paper
• Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies

  2021cites this paper
• Non-Rodent Genetic Animal Models for Studying Tauopathy: Review of Drosophila, Zebrafish, and C. elegans Models

  2021cites this paper
• The Structure Biology of Tau and Clue for Aggregation Inhibitor Design

  2021cites this paper
• Paired Helical Filament-Forming Region of Tau (297–391) Influences Endogenous Tau Protein and Accumulates in Acidic Compartments in Human Neuronal Cells

  2020cites this paper
• Biomolecular condensation of the microtubule-associated protein tau.

  2020cites this paper
• Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia

  2020cites this paper
• Arginine π-stacking drives binding to fibrils of the Alzheimer protein Tau

  2020cites this paper
• Zirconium(IV)-IMAC for phosphopeptide enrichment in phosphoproteomics

  2020cites this paper
• Liquid-liquid phase separation induces pathogenic tau conformations in vitro

  2020cites this paper
• Measuring Interactions Between Tau and Aggregation Inducers with Single-Molecule Förster Resonance Energy Transfer.

  2020cites this paper
• P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

  2020cites this paper
• Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell Death

  2020cites this paper
• Combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications

  2020cites this paper
• Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions

  2020cites this paper
• The structure and phase of tau: from monomer to amyloid filament

  2020cites this paper
• Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target

  2020cites this paper
• Zirconium(IV)-IMAC Revisited: Improved Performance and Phosphoproteome Coverage by Magnetic Microparticles for Phosphopeptide Affinity Enrichment.

  2020cites this paper
• LRP1 and SORL1 regulate tau internalization and degradation and enhance tau seeding

  2020cites this paper
• Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies

  2020cites this paper
• Selection of a d-Enantiomeric Peptide Specifically Binding to PHF6 for Inhibiting Tau Aggregation in Transgenic Mice.

  2020cites this paper
• Role of cysteines in accelerating Tau filament formation

  2020cites this paper
• Phosphorylation and Dephosphorylation of Tau Protein by the Catalytic Subunit of PKA, as Probed by Electrophoretic Mobility Retard

  2020cites this paper
• The role of wild-type tau in Alzheimer's disease and related tauopathies.

  2020cites this paper
• A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications

  2020influential citation
• Passive immunotherapies targeting Aβ and tau in Alzheimer's disease

  2020cites this paper
• Cornel iridoid glycoside induces autophagy to protect against tau oligomer neurotoxicity induced by the activation of glycogen synthase kinase-3β

  2019cites this paper
• Synthesis, chemical, theoretical studies, electrochemical, electrical and optical characterization of novel oligomer 2,2’-((1E,1’E)(2,5-bis(octyloxy)-1,4-phenylenevinylene)bis(6-(E)-2-(vinylquinolin))quinoline for OLED applications

  2019cites this paper
• Distinct Conformations, Aggregation and Cellular Internalization of Different Tau Strains

  2019cites this paper
• Analysis of Protein–Protein Functional Associations by Using Gene Ontology and KEGG Pathway

  2019cites this paper
• Intraneuronal Tau Misfolding Induced by Extracellular Amyloid-β Oligomers

  2019cites this paper
• Single Posttranslational Modifications in the Central Repeat Domains of Tau4 Impact its Aggregation and Tubulin Binding

  2019cites this paper
• The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?

  2019cites this paper
• Tau Oligomers.

  2019cites this paper
• Liquid-Liquid Phase Separation of Tau Protein in Neurobiology and Pathology.

  2019cites this paper
• A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain

  2019cites this paper
• Microtubules Gate Tau Condensation to Spatially Regulate Microtubule Functions

  2018cites this paper
• Lysophosphatidic acid induces neuronal cell death via activation of asparagine endopeptidase in cerebral ischemia‐reperfusion injury

  2018cites this paper
• Acetylation Disfavors Tau Phase Separation

  2018influential citation
• The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease

  2018cites this paper
• Lipid membrane templated misfolding and self-assembly of intrinsically disordered tau protein

  2018cites this paper
• Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease.

  2018cites this paper
• Reversible Cation-Selective Attachment and Self-Assembly of Human Tau on Supported Brain Lipid Membranes.

  2018cites this paper
• The involvement of the brain microenvironment in Alzheimer’s Disease

  2018cites this paper
• Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain

  2018cites this paper
• Caractérisation d'anticorps à domaine unique dirigés contre la protéine Tau

  2018cites this paper
• Diabetes and Alzheimer’s Disease

  2018cites this paper
• Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species

  2018cites this paper
• Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment

  2018cites this paper
• A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer’s Disease

  2018cites this paper
• Pathological missorting of endogenous MAPT/Tau in neurons caused by failure of protein degradation systems

  2018cites this paper
• Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry

  2018cites this paper